Company valuation is pathetic.
$5 to $6million valuation for a company with a fda approved drug--in a space valued at half a billion. Not to mention the transdermal Aggrastat delivery for which they have worldwide rights to.
Nothing like owning a publicly-traded company where management (paid by shareholders) can say absolutely nothing about the company's progress for months at a time.